Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy
- 31 July 2009
- journal article
- research article
- Published by Elsevier BV in Cytokine
- Vol. 47 (1), 37-42
- https://doi.org/10.1016/j.cyto.2009.04.001
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- TNF-α, but not IFN-γ, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosisAmerican Journal of Physiology-Renal Physiology, 2007
- TGF-β1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathwayAmerican Journal of Physiology-Renal Physiology, 2006
- Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated miceKidney International, 2006
- Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathyKidney International, 2005
- Blockade of CCR2 Ameliorates Progressive Fibrosis in KidneyThe American Journal of Pathology, 2004
- Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: Preliminary reportKidney International, 2003
- Advanced Glycation End Product-induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein-1 in Human-cultured Mesangial CellsPublished by Elsevier BV ,2002
- Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathyKidney International, 2000
- Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritisKidney International, 1996
- Cellular events in the evolution of experimental diabetic nephropathyKidney International, 1995